Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis
Clinical trial NCT04930042 · COMPLETED
Trial details
- NCT number
- NCT04930042
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2021-12-28
- Enrollment
- 581
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.